FEDERATED HERMES, INC. - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 263 filers reported holding MYRIAD GENETICS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$906,934
-30.8%
56,542
-0.0%
0.00%
-33.3%
Q2 2023$1,310,667
-3.2%
56,543
-3.0%
0.00%0.0%
Q1 2023$1,353,868
+65.1%
58,281
+3.2%
0.00%
+50.0%
Q4 2022$819,815
-22.5%
56,500
+1.9%
0.00%
-33.3%
Q3 2022$1,058,000
-24.6%
55,453
-28.2%
0.00%
-25.0%
Q2 2022$1,403,000
-50.2%
77,215
-30.9%
0.00%
-33.3%
Q1 2022$2,817,000
-16.6%
111,782
-8.6%
0.01%0.0%
Q4 2021$3,376,000
+12.7%
122,329
+31.8%
0.01%0.0%
Q3 2021$2,996,000
+50.3%
92,795
+42.4%
0.01%
+50.0%
Q2 2021$1,993,000
+0.1%
65,168
-0.4%
0.00%0.0%
Q1 2021$1,992,000
+39.5%
65,427
-9.4%
0.00%
+33.3%
Q4 2020$1,428,000
-85.4%
72,235
-90.4%
0.00%
-87.0%
Q3 2020$9,806,000
-36.5%
751,983
-44.8%
0.02%
-39.5%
Q2 2020$15,439,000
+38.8%
1,361,424
+75.2%
0.04%
+15.2%
Q1 2020$11,122,000
+227.9%
777,205
+536.6%
0.03%
+312.5%
Q2 2019$3,392,000
+22.3%
122,085
+46.2%
0.01%
+14.3%
Q1 2019$2,773,000
-22.3%
83,515
-32.0%
0.01%
-30.0%
Q4 2018$3,568,000
-66.0%
122,727
-46.2%
0.01%
-58.3%
Q3 2018$10,484,000
+32.4%
227,919
+7.5%
0.02%
+4.3%
Q2 2018$7,920,000
+178.8%
211,926
+120.4%
0.02%
+187.5%
Q1 2018$2,841,000
+2154.8%
96,142
+2524.0%
0.01%
Q4 2017$126,000
-5.3%
3,6640.0%0.00%
Q3 2017$133,000
+37.1%
3,664
-2.0%
0.00%
Q2 2017$97,000
+34.7%
3,7390.0%0.00%
Q1 2017$72,000
+16.1%
3,7390.0%0.00%
Q4 2016$62,000
-20.5%
3,739
-1.7%
0.00%
Q3 2016$78,000
-32.8%
3,8050.0%0.00%
Q2 2016$116,000
-79.5%
3,805
-74.8%
0.00%
-100.0%
Q1 2016$565,000
+250.9%
15,096
+304.7%
0.00%
+100.0%
Q4 2015$161,000
+15.0%
3,730
+0.1%
0.00%
Q3 2015$140,000
-77.8%
3,728
-79.9%
0.00%
-100.0%
Q2 2015$630,000
+180.0%
18,542
+191.9%
0.00%
+100.0%
Q1 2015$225,000
-85.9%
6,353
-86.5%
0.00%
-80.0%
Q4 2014$1,599,000
-9.9%
46,945
+2.1%
0.01%
-16.7%
Q3 2014$1,774,000
-0.9%
45,9910.0%0.01%0.0%
Q2 2014$1,790,000
+14.6%
45,991
+0.7%
0.01%
+20.0%
Q1 2014$1,562,000
+63.0%
45,674
+0.0%
0.01%
+66.7%
Q4 2013$958,000
+104.3%
45,667
+129.1%
0.00%
+50.0%
Q3 2013$469,000
+7716.7%
19,937
+8568.3%
0.00%
Q2 2013$6,0002300.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders